Latest filing published 13 Apr 2020 for Catalent, Inc., €14k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Peter L. Buzy has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Martek Biosciences Corp and Catalent, Inc. In total, 21 filings cover trades dated from 4 April 2007 to 9 April 2020.
The open-market side counts 2 purchases for €1.9M alongside 1 sale for €780k. The net balance comes to €1.1M on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 7 share grants and 5 option exercises.
The latest filing, published on 13 April 2020, reports a share grant of €14k in Catalent, Inc. The latest purchase dates back some time: it was published 2,704 days ago, on 30 May 2019. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations